Chemoinformaics analysis of Methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate
Molecular Weight | 210.229 | nRot | 1 |
Heavy Atom Molecular Weight | 196.117 | nRig | 7 |
Exact Molecular Weight | 210.089 | nRing | 1 |
Solubility: LogS | -2.526 | nHRing | 0 |
Solubility: LogP | 2.867 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 30.9131 |
nHD | 2 | BPOL | 16.6489 |
QED | 0.694 |
Synth | 2.295 |
Natural Product Likeliness | 0.987 |
NR-PPAR-gamma | 0.212 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.006 |
HIA | 0.017 |
CACO-2 | -4.74 |
MDCK | 0.0000166 |
BBB | 0.296 |
PPB | 0.968366 |
VDSS | 0.548 |
FU | 0.0288514 |
CYP1A2-inh | 0.914 |
CYP1A2-sub | 0.951 |
CYP2c19-inh | 0.15 |
CYP2c19-sub | 0.733 |
CYP2c9-inh | 0.193 |
CYP2c9-sub | 0.675 |
CYP2d6-inh | 0.1 |
CYP2d6-sub | 0.378 |
CYP3a4-inh | 0.161 |
CYP3a4-sub | 0.216 |
CL | 14.399 |
T12 | 0.818 |
hERG | 0.007 |
Ames | 0.103 |
ROA | 0.075 |
SkinSen | 0.664 |
Carcinogencity | 0.066 |
EI | 0.949 |
Respiratory | 0.208 |
NR-Aromatase | 0.306 |
Antiviral | No |
Prediction | 0.701949 |